Your browser doesn't support javascript.
loading
Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan.
Molina-de la Fuente, Irene; Sagrado Benito, María José; Lasry, Estrella; Ousley, Janet; García, Luz; González, Vicenta; Pasquale, Harriet Akello; Julla, Ahmed; Uwiragiye, Piex; Abdi, Abdirashid M; Chol, Buai Tut; Abubakr, Bakri; Benito, Agustín; Casademont, Cristian; Berzosa, Pedro; Nanclares, Carolina.
  • Molina-de la Fuente I; Alcala University, Madrid, Spain.
  • Sagrado Benito MJ; Institute of Health Carlos III, Madrid, Spain.
  • Lasry E; Médecins Sans Frontières, Carrer de Zamora, 54, 08005, Barcelona, Spain. Mariajose.sagrado@barcelona.msf.org.
  • Ousley J; Médecins Sans Frontières, Carrer de Zamora, 54, 08005, Barcelona, Spain.
  • García L; Médecins Sans Frontières, New York, NY, USA.
  • González V; Institute of Health Carlos III, Madrid, Spain.
  • Pasquale HA; Institute of Health Carlos III, Madrid, Spain.
  • Julla A; National Malaria Control Programme, Ministry of Health, Juba, South Sudan.
  • Uwiragiye P; National Malaria Control Programme, Ministry of Health, Juba, South Sudan.
  • Abdi AM; Médecins Sans Frontières, Juba, South Sudan.
  • Chol BT; Médecins Sans Frontières, Juba, South Sudan.
  • Abubakr B; Médecins Sans Frontières, Juba, South Sudan.
  • Benito A; Médecins Sans Frontières, Nairobi, Kenya.
  • Casademont C; Institute of Health Carlos III, Madrid, Spain.
  • Berzosa P; Centro de Investigación Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
  • Nanclares C; Médecins Sans Frontières, Carrer de Zamora, 54, 08005, Barcelona, Spain.
Malar J ; 22(1): 345, 2023 Nov 10.
Article en En | MEDLINE | ID: mdl-37950227
ABSTRACT

BACKGROUND:

Seasonal malaria chemoprevention (SMC) using sulfadoxine-pyrimethamine plus amodiaquine (SP-AQ), is a community-based malaria preventive strategy commonly used in the Sahel region of sub-Saharan Africa. However, to date it has not been implemented in East Africa due to high SP resistance levels. This paper is a report on the implementation of SMC outside of the Sahel in an environment with a high level of presumed SP-resistance five cycles of SMC using SPAQ were administered to children 3-59 months during a period of high malaria transmission (July-December 2019) in 21 villages in South Sudan.

METHODS:

A population-based SMC coverage survey was combined with a longitudinal time series analysis of health facility and community health data measured after each SMC cycle. SMC campaign effectiveness was assessed by Poisson model. SPAQ molecular resistance markers were additionally analysed from dried blood spots from malaria confirmed patients.

RESULTS:

Incidence of uncomplicated malaria was reduced from 6.6 per 100 to an average of 3.2 per 100 after SMC administration (mean reduction 53%) and incidence of severe malaria showed a reduction from 21 per 10,000 before SMC campaign to a mean of 3.3 per 10,000 after each cycle (mean reduction 84%) in the target group when compared to before the SMC campaign. The most prevalent molecular haplotype associated with SP resistance was the IRNGE haplotype (quintuple mutant, with 51I/59R/108N mutation in pfdhfr + 437G/540E in pfdhps). In contrast, there was a low frequency of AQ resistance markers and haplotypes resistant to both drugs combined (< 2%).

CONCLUSIONS:

The SMC campaign was effective and could be used as an additional preventive tool in seasonal malaria settings outside of the Sahel, especially in areas where access to health care is unstable. Malaria case load reduction was observed despite the high level of resistance to SP.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Malaria / Antimaláricos Límite: Child / Humans País como asunto: Africa Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Malaria / Antimaláricos Límite: Child / Humans País como asunto: Africa Idioma: En Año: 2023 Tipo del documento: Article